{"id":1024139,"date":"2021-08-14T01:05:50","date_gmt":"2021-08-14T05:05:50","guid":{"rendered":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/amgen-amgn-gains-0-67-in-light-trading-on-august-13-equities-com\/"},"modified":"2021-08-14T01:05:50","modified_gmt":"2021-08-14T05:05:50","slug":"amgen-amgn-gains-0-67-in-light-trading-on-august-13-equities-com","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/human-genetics\/amgen-amgn-gains-0-67-in-light-trading-on-august-13-equities-com\/","title":{"rendered":"AMGEN (AMGN) gains 0.67% in Light Trading on August 13 &#8211; Equities.com"},"content":{"rendered":"<p><p>Last Price$ Last TradeChange$ Change Percent %Open$ Prev Close$ High$ low$ 52 Week High$ 52 Week Low$ Market CapPE RatioVolumeExchange<\/p>\n<p>AMGN - Market Data & News<\/p>\n<p>AMGEN Inc. (NASDAQ: AMGN) shares gained 0.67%, or $1.53 per share, to close Friday at $229.68. After opening the day at $229.11, shares of AMGEN fluctuated  between $231.89 and $228.76. 1,797,295 shares traded hands a decrease from their 30 day average of 2,416,949. Friday's activity brought AMGENs market cap to $130,424,328,437.<\/p>\n<p>AMGEN is headquartered in Thousand Oaks, California, and employs more than 22000 people.<\/p>\n<p>Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.<\/p>\n<p>Visit AMGEN Inc.s profile for more information.<\/p>\n<p>The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook. <\/p>\n<p>To get more information on AMGEN Inc. and to follow the companys latest updates, you can visit the companys profile page here:  AMGEN Inc.s Profile. For more news on the financial markets be sure to visit Equities News. Also, dont forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.<\/p>\n<p>Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.<\/p>\n<p>DISCLOSURE:The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: <a href=\"http:\/\/www.equities.com\/disclaimer\" rel=\"nofollow\">http:\/\/www.equities.com\/disclaimer<\/a><\/p>\n<p><!-- Auto Generated --><\/p>\n<p>More:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.equities.com\/news\/amgen-amgn-gains-0-67-in-light-trading-on-august-13\" title=\"AMGEN (AMGN) gains 0.67% in Light Trading on August 13 - Equities.com\" rel=\"noopener\">AMGEN (AMGN) gains 0.67% in Light Trading on August 13 - Equities.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Last Price$ Last TradeChange$ Change Percent %Open$ Prev Close$ High$ low$ 52 Week High$ 52 Week Low$ Market CapPE RatioVolumeExchange AMGN - Market Data &#038; News AMGEN Inc. (NASDAQ: AMGN) shares gained 0.67%, or $1.53 per share, to close Friday at $229.68.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/human-genetics\/amgen-amgn-gains-0-67-in-light-trading-on-august-13-equities-com\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[],"class_list":["post-1024139","post","type-post","status-publish","format-standard","hentry","category-human-genetics"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1024139"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=1024139"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1024139\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=1024139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=1024139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=1024139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}